J&J, Amgen Scrutinized For Anemia Drug Marketing
Congressional leaders have asked Johnson & Johnson and Amgen Inc. to turn over records related to the advertising and marketing of their anemia drugs amid reports of increased risks of blood...To view the full article, register now.
Already a subscriber? Click here to view full article